Prof. Dr. Hermann Einsele (@h_einsele) 's Twitter Profile
Prof. Dr. Hermann Einsele

@h_einsele

Chair of the department of Internal Medicine II & head of the clinical & translational research program on myeloma in Wuerzburg-DEU. Tweets & opinions are mine.

ID: 1097801166040297472

calendar_today19-02-2019 10:12:48

137 Tweet

613 Followers

32 Following

Robert Z. Orlowski (@myeloma_doc) 's Twitter Profile Photo

#Myeloma Paper of the Day: Phase II study of#Pomalyst/#Darzalex/dex given immediately after #Revlimid-based treatment in patients with #myeloma finds 77.7% response rate & median PFS of 30.8 months: pubmed.ncbi.nlm.nih.gov/35133221/.

#Myeloma Paper of the Day: Phase II study of#Pomalyst/#Darzalex/dex given immediately after #Revlimid-based treatment in patients with #myeloma finds 77.7% response rate & median PFS of 30.8 months: pubmed.ncbi.nlm.nih.gov/35133221/.
Multiple Myeloma Hub (@mm_hub) 's Twitter Profile Photo

CONGRESS | #COMy22 | Prof. Dr. Hermann Einsele, Universität Würzburg #UniWürzburg, discussed integrating immune therapies and autologous transplantation, including arguments for moving CAR-T and bispecific antibodies to earlier lines of therapy #mmsm #myeloma

CONGRESS | #COMy22 | <a href="/H_Einsele/">Prof. Dr. Hermann Einsele</a>, <a href="/Uni_WUE/">Universität Würzburg #UniWürzburg</a>, discussed integrating immune therapies and autologous transplantation, including arguments for moving CAR-T and bispecific antibodies to earlier lines of therapy

#mmsm #myeloma